The phosphatase and tensin homology deleted on chromosome 10 ( PTEN ) is a tumor suppressor gene with sequence homology to tyrosine phosphatases and the cytoskeletal proteins tensin and auxilin. PTEN has recently been shown to inhibit cell migration and the spreading and formation of focal adhesions. This study investigated the role of PTEN in carcinoma invasion in a lung-cancer cell line and examined the downstream genes regulated by PTEN . We have previously established a cell-line model in human lung adenocarcinoma with different invasive abilities and metastatic potentials. Examining PTEN gene expression in these cell lines, we found that a homozygous deletion in exon 5 is associated with high invasive ability. We then constructed stable constitutive and inducible wild-type PTENoverexpressed transfectants in the highly invasive cell line CL 1-5 . We found that an overexpression of PTEN can inhibit invasion in lung cancer cells. To further explore the downstream genes regulated by PTEN , a high-density complementary DNA (cDNA) microarray technique was used to profile gene changes after PTEN overexpression. Our results indicate a panel of genes that can be modulated by PTEN . PTEN overexpression downregulated genes, including integrin ␣ 6 , laminin ␤ 3 , heparin-binding epidermal growth factor-like growth factor, urokinase-type plasminogen activator, myb protein B, Akt2, and some expressed sequence tag (EST) clones. In contrast, PTEN overexpression upregulated protein phosphatase 2A1B, ubiquitin protease (unph), secreted phosphoprotein 1, leukocyte elastase inhibitor, nuclear factor-B, cyclic adenosine monophosphate response element binding protein, DNA ligase 1, heat shock protein 90, and some EST genes. Northern hybridization and flow cytometry analysis also confirmed that PTEN overexpression results in the reduced expression of the integrin ␣ 6 subunit. The results of this study indicate that PTEN overexpression may inhibit lung cancer invasion by downregulation of a panel of genes including integrin ␣ 6 . The cDNA microarray technique may be an effective tool to study the downstream function of a tumor suppressor gene.
The phosphatase and tensin homology deleted on chromosome 10 ( PTEN ) gene, also known as "mutated in multiple advanced cancers 1" or "transforming growth factor-␤ -regulated and epithelial cell-enriched phosphatase," was recently identified as a tumor suppressor gene located at chromosome 10q 23.3 (1) (2) (3) . Germline mutations of PTEN have been found to be linked to Cowden syndrome, an autosomal disorder characterized by harmartomas and increased susceptibility to breast and thyroid cancers (4) . Inactivation of the PTEN gene has recently been detected in several types of human tumors, including glioblastoma, breast cancer, kidney cancer, prostate cancer, melanoma, endometrial cancer, and lung cancer (5) (6) (7) (8) (9) (10) . The exact function of the PTEN is not known. Previous studies demonstrated that the wild-type PTEN gene has a tumor suppressor activity in isolated cancer cells (11) . Overexpression of the exogenous wild-type PTEN by transfection may inhibit the proliferation of glioma cell lines (11) .
Adenovirus-mediated transfer of wild-type PTEN gene into glioma cells can suppress tumorigenicity in nude mice (12) . Recently, it has been demonstrated that the PTEN gene may encode a cytoplasmic protein that has a protein tyrosine phosphatase domain and a domain extensively homologous to the cytoskeletal proteins, tensin and auxilin (1, 2, 11) . These findings suggest that the PTEN gene may affect integrin or cytoskeletal function, and overexpression of PTEN can inhibit cell migration and the spreading and formation of focal adhesions (13) . In the present study we investigated the role of PTEN in lung cancer invasion.
We previously established a cell-line model in human lung adenocarcinoma with different invasive abilities and metastatic potentials (14) . By examining PTEN expression in these cell lines, we found that a homozygous deletion in exon 5 is associated with the high invasive ability of the cell line. We then used this highly invasive cell line to construct stable constitutive and inducible wild-type PTEN expression transfectants. We found that overexpression of the PTEN gene can inhibit lung cancer cell invasion. We further explored the possible cellular functions, as well as the downstream gene expression regulated by the PTEN gene, using a high-density complementary DNA (cDNA) microarray system to identify differentially expressed genes in PTEN -overexpressed cells (15) . Several genes related to carcinoma invasion were identified using this technique.
Materials and Methods

Cell Lines
Human lung adenocarcinoma cell lines of different invasive and metastatic capacities, CL 1-0 , CL 1-1 , and CL [1] [2] [3] [4] [5] (14) , were grown in RPMI #1640 medium with 10% fetal bovine serum (FBS) at 37 Њ C, 20% O 2 , and 5% CO 2 . CL 1-0 is the parent cell line; CL 1-1 and CL [1] [2] [3] [4] [5] are sublines selected from CL by in vitro selection with polycarbonate membrane coating with Matrigel (Collaborative Biomedical, Becton Dickinson, Bedford, MA) in a Transwell invasion chamber (14) . CL [1] [2] [3] [4] [5] has the highest invasive ability, CL has invasive ability in between those of CL 1-0 and CL [1] [2] [3] [4] [5] , and CL 1-0 has the lowest invasive ability.
Reverse Transcriptase/Polymerase Chain Reaction Analysis and DNA Sequencing
Total RNA from the cell lines and transfectant cells was isolated by the single-step acid guanidinium thiocyanate-phenol-chloroform extraction method as previously described by Chomczynski and Sacchi (16) . The RNA was reverse transcribed using murine leukemia virus reverse transcriptase (RT) (RNA PCR kit; Perkin-Elmer, Emeryville, CA), random hexamer, and other kit reagents, followed by polymerase chain reaction (PCR). A cDNA encoding the entire human PTEN open reading frame (1,200 base pairs [bp]) was amplified from the placenta library by PCR using sense primer 5 Ј -GGA TCC GAC ATG ACA GCC ATC ATC AAA G-3 Ј and antisense primer 5 Ј -CTC GAG TCA GAC TTT TGT AAT TTG TGA ATG CTG-3 Ј . The PTEN 5 Ј primer (5 Ј -ATG ACA GCC ATC ATC AAA GAG-3 Ј ) and PTEN 3 Ј primer (5 Ј -TCA GAC TTT TGR AAT TTG TGT ATG-3 Ј ) were used for analysis of PTEN expression in pIND PTEN transfectants. The primers for RT-PCR amplification for examining PTEN expression of the pCEP4 transfectant were 5 Ј primer 5 Ј -ATG ACA GCC ATC ATC AAA GAG-3 Ј and 3 Ј primer 5 Ј -GTG GTTT TGT CCA AAC TCA TC-3 Ј . The PCR was performed with a total of 25 cycles of 94 Њ C for 1 min, 55 Њ C for 1 min, and then 72 Њ C for 3 min, and final extension for 10 min at 72 Њ C. The PCR products were then cut from agarose gels, purified, and directly sequenced using an automated sequencing system (ABI 373A; Perkin-Elmer). Finally, the sequences were analyzed and compared with the wild-type PTEN sequence with DNAStar software (DNAStar Inc., Madison, WI).
Plasmid Construction and Transfection
An ecdysone expression system using pIND and pCEP4 plasmids (Invitrogen, Carlsbad, CA) was selected to establish stable PTEN transfectants (13) . pIND PTEN and pCEP4 PTEN were created by inserting the full-length human PTEN cDNA between the Hin dIII and Bam HI sites of pIND and pCEP4 plasmids, respectively. All contracts were sequenced entirely to eliminate PCRgenerated artifacts. The CL 1-5 cells with homozygous deletion of exon 5 were selected for transfection study. The transfection experiment was carried out with pIND and pCEP4 plasmids containing the full-length PTEN cDNA insert or with plasmids containing no insert. For constitutive PTEN expression transfectants, 1 ϫ 10 6 CL 1-5 cells were plated in RPMI #1640 and 10% FBS and grown to 50% confluency. The cells were then transfected with pCEP4-based expression vector, with plasmid containing either the full-length PTEN insert or vector alone and lipofectin (GIBCO BRL, Gaithersburg, MD). Hygromycin B was added to a concentration of 250 g/ml for selection of stable constitutive PTEN -expressing transfectant.
A pVg RXR vector was selected to isolate the inducible transfectants (13) . The pVg RXR is a vector that expresses both ecdysone receptor and retinoid X receptor (RXR), is driven by cytomegalovirus and Rous sarcoma virus promoters, and can be selected by zeocin antibiotics. The 1 ϫ 10 6 CL 1-5 cells were grown to 50% confluency in a 60-mm dish and then cotransfected with 5 g pIND and 5 g pVg RXR in the presence of 40 g lipofectin. Gentamicin-G418 (400 g/ml) and zeocin (200 g/ml) were added for selection of transfectant. The stable transfectants were then isolated 3 wk later using a ring-cloned technique.
Immunocytochemical Study and Western Blot Analysis
A mouse monoclonal antibody (mAb) (PTEN A2B1, immunoglobulin [Ig] G; Santa Cruz Biotechnology, Santa Cruz, CA), that recognizes the epitope corresponding to amino acids 388 to 400, mapping at the carboxyl terminus of the PTEN gene, was used for immunostaining and Western blot analysis to confirm the protein expression in the transfectants. The cultured cells were fixed directly with cold methanol-acetone (1:1, vol/vol) on plastic coverslips (Miles Laboratories, Naperville, IL). The fixed cells were washed with phosphate-buffered saline (PBS). After blocking with 5 mg/ml bovine serum albumin (BSA), coverslips were incubated with either mAb PTEN A2B1 (1 g/ml) or an irrelevent mouse control antibody, followed by fluorescein-conjugated goat antimouse IgG secondary antibody (Vector Laboratories, Burlingame, CA). The cells were examined and photographed using a Zeiss Axiphot epifluoresence microscope equipped with MRC-600 laser scanning confocal imaging system (Bio-Rad, Rockville Center, NY).
For Western blot analysis, total cell lysates (50 g of protein each lane) were separated with 12.5% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis and transferred to an Immobilon membrane (Millipore, Bedford, MA). The proteins were detected with mAb PTEN A2B1, followed by the use of a biotinylated antimouse secondary antibody (Vector Laboratories). The protein bands were chromagenically stained with avidin and horseradish peroxidase (Vectastain ABC Kit; Vector Laboratories).
Cell Growth and In Vitro Invasion Assay
From each of the stable transfectants, 1 ϫ 10 5 cells were seeded in triplicate at each time point into six-well plates. After incubation for 24, 48, or 72 h, the cells were then trypsinized and the viable cells were counted by the trypan blue dye exclusion method using a hemocytometer.
The membrane invasion culture system (MICS) was used to measure a cell line's invasive ability (14) . A polycarbonate membrane containing 10-m pores (Nucleopore Corp., Pleasanton, CA) was coated with a mixture of laminin (50 g/ml; Sigma Chemical Co., St. Louis, MO), type IV collagen (50 g/ml; Sigma), and gelatin (2 mg/ml; Bio-Rad, Hercules, CA) in 10 mM glacial acetic acid solution. The membrane was placed between the upper-and lowerwell plates of the MICS chamber. Cells were then resuspended in RPMI #1640 containing 10% NuSerum and seeded into the upper wells of the chamber (5 ϫ 10 4 cells/well). After incubation for 24 h at 37 Њ C, cells that had invaded the coated membrane were removed from the lower wells with 1 mM ethylenediaminetetraacetic acid (EDTA) in PBS, and dot-blotted onto a 3-m polycarbonate membrane. After fixation in methanol, blotted cells were stained with Liu stain (Handsel Technologies, Inc., Taipei, Taiwan), and the cell number in each blot was microscopically counted. Each experiment with the transfectant cell lines was repeated in triplicate.
Profiling of Gene Expression Pattern in PTEN Transfectants Using the cDNA Microarray System
To profile the gene expression patterns regulated by PTEN , messenger RNAs (mRNAs) from stable transfected cell lines with or without constitutive wild-type PTEN expression were extracted using oligotex-dT resin (Qiagen, Hilden, Germany). The quantity of 1 g of each mRNA sample was labeled with biotin for color detection. The labeling reactions were done during reverse transcription in the presence of 6 M random primers; 0.5 mM each of deoxyadenosine triphosphate, deoxycytidine triphosphate, and deoxyguanidine triphosphate; 40 M deoxythymidine triphosphate; 40 M biotin-16-deoxyuridine triphosphate (dUTP) (Boehringer Mannheim, Mannheim, Germany); 10 mM dithiothreitol; 0.5 unit/l RNasin (GIBCO-BRL); and 200 units of MMLV RT (GIBCO-BRL) in a 50 l solution.
A cDNA microarray system and membranes (Boehringer Mannheim) were prepared as previously described (15) . The cDNA microarray membrane contains 9,600 nonredundant expressed se-quence tag (EST) clones with putative gene names selected from the IMAGE consortium human cDNA libraries on the basis of the insert length and sequence of the EST clones in the Unigene database (17) . These 9,600 nonredundant EST clones served as the hybridization target. The membrane carrying the doublestranded cDNA targets was prehybridized in 1 ml hybridization buffer (5ϫ saline sodium citrate [SSC], 0.1% N-lauroylsarcosine, 0.1% SDS, 1% blocking reagent mixture (Boehringer Mannheim), and 50 g/ml salmon sperm DNA) at 68ЊC for 1 h before hybridization.
After hybridization, the membrane was blocked by 1 ml of 1% blocking reagent (Boehringer Mannheim) containing 2% dextran sulfate at room temperature for 1 h and then rinsed with 1ϫ Tris-buffered saline (TBS) buffer solution (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, and 0.3% BSA). The membrane was incubated for 2 h with a 1-ml mixture containing 700ϫ diluted STREP-GAL (1.38 U/ml, enzyme activity) (GIBCO-BRL), 4% polyethylene glycol 8000 (Sigma), and 0.3% BSA in 1ϫ TBS buffer. The membrane was then washed with 1ϫ TBS buffer three times for 5 min each. The color development reactions were then stopped by 1ϫ PBS containing 20 mM EDTA.
The quantification was done by the Mu CDA program written in-house and is available via anonymous ftp at ftp://genestamp. ibms.sinica.edu.tw. The program isolates differentially expressed genes by measuring the integrated density of each spot, performing regression analysis on the integrated density data, and locating the statistical outliers as differentially expressed genes.
Northern Hybridization
To confirm the results of gene detection by the cDNA microarray system, the differentially expressed cDNA clones were selected from the array membrane and the entire inserts of the clones were individually PCR-amplified to serve as probes for Northern hybridization. A 1-g quantity of mRNA from various PTEN transfectants was isolated and poly (A ϩ ) mRNA was purified by two passes of total RNA over an oligo (dT)-cellulose column. Equal amounts of RNA were electrophoresed on 1.2% agarose gel in the presence of 2.2 mM formaldehyde and transblotted onto a nylon membrane. The nylon membranes were baked at 80ЊC in a vacuum for 2 h. The membranes were then prehybridized at 68ЊC in a solution containing 6ϫ SSC, 10 mM EDTA, 5ϫ Denhardt's solution, 0.5% SDS, and 100 g/ml sheared salmonsperm RNA. The PCR-amplified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs were [ 32 P]-labeled by the random prime labeling system (Amersham Pharmacia Biotech, Piscataway, NJ). The hybridization was carried out at 68ЊC for 24 h. The filters were washed twice in 2ϫ SSC/0.1% SDS at room temperature for 15 min, followed by one 30-min wash in 0.1ϫ SSC/ 0.1% SDS. The relative abundance of individual gene mRNA in each transfectant was normalized with the GAPDH mRNA band that hybridized to the [ 
Flow Cytometry Analysis of Integrin ␣ 6 Expressions
The stable constitutive transfectant pCEP4 PTEN cells were subjected to indirect immunofluorescence staining for the expression of surface integrin ␣ 6 using murine mAb against human integrin ␣ 6 (BQ16; Acell Co., Bayport, MN). Each of the transfectant cells was grown to subconfluence and then harvested from the tissuecultured flask with 1 mM EDTA. Cells were fixed for 30 min at 4ЊC in 2.5% paraformaldehyde, washed, and then blocked with 20% goat whole serum. The cells were then incubated with antiintegrin ␣ 6 mAbs for 45 min at room temperature and washed three times with PBS. Subsequently, cells were incubated with fluorescein-conjugated goat anti-mouse IgG for 45 min at room temperature and again washed 3 times with PBS. Finally, the flu- 
Results
Expression of the PTEN Gene in CL 1 Cells and Transfectants
The expression of the PTEN gene in CL 1 cells with different invasive abilities was examined by RT-PCR using PTENspecific primers and direct sequencing, as shown in Figure 1 Figure  2A shows the results of RT-PCR using PTEN-specific primers, in which overexpression of wild-type PTEN gene could be induced in pIND PTEN (ϩ) transfectant. In addition, we also established stable constitutive wild-type PTEN expression clones by using pCEP4 vector in CL [1] [2] [3] [4] [5] cells. Six clones were selected, namely clones 9, 10, 13, 17, 6, and 16. Clones 13, 17, 6, and 16 contained full-length PTEN cDNA, whereas clones 10 and 9 contained vector alone. Figure 2B shows the results of RT-PCR using wildtype PTEN-specific primers. Clones 13, 17, 6 and 16 expressed wild-type PTEN, whereas clones 9 and clone 10 did not. Northern hybridization was then used to examine Figure 5A shows the results of in vitro invasion assay in PTEN-overexpressed clones as compared with those of the control clones. In stable constitutive PTEN-expression transfectants, clones 6 and 16, which exhibited PTEN overexpression, showed an invasion rate that was reduced by about 50% compared with the control clones (clones 9 and 10). Cell proliferation analysis revealed that PTEN-overexpressed clones did not show any significant reduction in cell growth ( Figure  6 ). In the ecdysone-inducible PTEN expression system, the pIND PTEN (ϩ) cells showed a dose-dependent reduction in invasion ability after induction of PTEN expression by muristerone A (Figure 5B ). These data indicate that overexpression of PTEN can inhibit invasion in CL 1-5 cells.
In Vitro Invasion Assay and Cell Growth in PTEN-Overexpressed Clones
Isolation of Differentially Expressed Genes Regulated by PTEN Using the cDNA Microarray System
The stable transfectants, which constitutively overexpressed PTEN, were chosen for cDNA microarray analysis. The Figure 2 . The expression of wild-type PTEN and exon 5-deleted PTEN mutant in the stable transfected cell lines were examined by RT-PCR with specific primers after transfection of the wildtype PTEN gene. In the ecdysone-inducible PTEN expression system (A), pIND PTEN (ϩ) clone expressed a small amount of wild-type PTEN, whereas after 1 M muristerone A treatment for 5 d, overexpression of wild-type PTEN could be induced. In the PTEN constitutive overexpression experiments using pCEP4 vectors, clones 13, 17, 6, and 16 contained full-length PTEN cDNA, whereas clones 9 and 10 contained vector alone. The RT-PCR with specific primer showed that clones 13, 17, 6, and 16 expressed wild-type PTEN, whereas clones 9 and 10 did not (B). Northern hybridization was performed to analyze wild-type PTEN expression in clones 9 and 10 (vector alone) and clones 16 and 6 (PTENpositive) (C). Full-length cDNA, 1.2 kb, was used as a probe. Northern hybridization revealed that clones 16 and 6 expressed high levels of wild-type and mutant forms of the PTEN mRNA whereas clones 9 and 10 showed only mutant form. The transfected wild-type PTEN mRNA does not contain 3Ј and 5Ј untranslated region, which is smaller in size as compared with mutant form. Mt: mutant form, Wt: wild-type, delx5: exon 5 deletion. the PTEN mRNA expression level among these PTEN transfectants, as shown in Figure 2C . A 20-fold overexpression of wild-type PTEN mRNA was observed in clones 6 and 16 as compared with the control clones (clones 9 and 10).
Expression of PTEN Proteins in the Transfected Cells
The expression of PTEN proteins in the transfectants was investigated by a mAb PTEN A2B1, which specifically recognized the carboxyl terminus of the PTEN gene product. Figure 3 shows the immunofluorescent staining of wildtype PTEN-overexpressed cells (clone 16) and the mock transfectants (clone 10). Wild-type PTEN proteins were expressed diffusely in the cytoplasm of clone 16 cells. The clone 10 cells contained only truncated proteins which cannot be recognized by A2B1 antibody. Western blot analy-mRNA of each stable PTEN transfectant mRNA was isolated and then hybridized to the cDNA microarray membrane. A total of 9,600 cDNA clones in the microarray membrane were analyzed. The array signal intensities of PTEN-overexpressed clone (clone 16) were compared with intensities of the mock clone (clone 10) transfected with empty vector. As shown in Figure 7 , most of the spots showed the same signal intensities, however some of the spots revealed different signal intensities. After computer analysis and normalization with control, a 2-fold difference in signal intensities was arbitrarily chosen and considered significant. An example of a close-up view shown in Figure 7 reveals that integrin ␣ 6 and an EST cDNA clone were differentially expressed in wild-type PTEN-overexpressed cells as compared with the control clone. The array hybridization was repeated four times with the same clones on four different arrays, using a new array for each experiment. Only those cDNA clones which constantly showed at least 2-fold difference were selected for further analysis. Tables 1 and 2 show panels of putative genes that were differentially expressed in PTEN-overexpressed clones. Some of these genes were inhibited after PTEN overexpression, including laminin ␤ 3 , integrin ␣ 6 , human mRNA for Drg1, myb-related protein B, Akt2, and some EST genes. Some of the putative genes were stimulated by PTEN overexpression, including protein phosphatase 2A1B, leukocyte elastase inhibitor, nuclear factor (NF)-B, cyclic adenosine monophosphate response element binding protein (CREB), heat shock protein 90, trans-golgi network (TGN 46), DNA ligase 1, ubiquitin protease (unph), and some EST genes. Among these differentially expressed genes, integrin ␣ 6 , laminin ␤ 3 , Akt2, and protein phosphatase 2A1B have previously been reported to be associated with carcinoma invasion (18) (19) (20) (21) (22) (23) . Figure 8 shows the Northern hybridizations of representative genes differentially expressed in PTEN-overexpressed clones and mock clones. The heparin-binding epidermal growth factor (EGF)-like growth factor, RTP genes, Akt2 genes, and integrin ␣ 6 were suppressed by PTEN overexpression, whereas ubiquitin protease (unph) and some EST genes were upregulated by PTEN overexpression.
Northern Hybridization Analysis of PTEN-Regulated Genes
Flow Cytometry Analysis of Integrin ␣ 6 Expression
Because the cDNA microarray study showed that integrin ␣ 6 genes are downregulated by PTEN overexpression, we carried out a flow cytometry analysis for integrin ␣ 6 subunit protein expressions. The stable constitutive transfec- tants of pCEP PTEN cells were subjected to indirect immunofluoresence staining using mAb against integrin ␣ 6 . The PTEN-overexpressed clones (clones 6 and 16) showed reduced integrin ␣ 6 expression as compared with the mock transfectants (clones 10 and 9) ( Figure 9A ). In the ecdysoneinducible PTEN expression system, the pIND PTEN (ϩ) cells also showed reduction in integrin ␣ 6 expression after induction of PTEN expression by 1 M muristerone A ( Figure 9B ). The flow cytometry studies confirmed that PTEN overexpression might downregulate integrin ␣ 6 subunit expression at the protein level.
Discussion
The results of this study demonstrate that exon 5 deletion of PTEN is associated with a high invasive ability in our human lung cancer metastatic cell line model. Overexpression of wild-type PTEN inhibited the invasive ability of these cells. We further investigated the downstream genes regulated by PTEN expression using high-density cDNA microarray techniques. Several differentially expressed genes associated with carcinoma migration and invasion were identified which could be modulated by expression of PTEN, including integrin ␣ 6 , laminin ␤ 3 , Akt2, and protein phosphatase 2A1B. We also found a panel of genes that could be modulated by PTEN expression. The PTENdownregulated genes included heparin-binding EGF-like growth factor, a transcription inhibitor 1d-2H, urokinasetype plasminogen-activator, Myb-related protein B, S-arrestin, and some EST clones. The PTEN-upregulated genes included leukocyte elastase inhibitor, ubiquitin protease (unph), secreted phosphoprotein 1, human canalicular multispecific organic anion transporter, Not 56-like protein, NF-B, clK3, CREB, protein phosphatase 2A1B, DNA ligase 1, trans-golgi network protein (TGN 46), glutamyl aminopeptidase A, and others. Northern hybridization and flow cytometry analysis confirmed the downregulation of integrin ␣ 6 by PTEN both in mRNA and at the protein level. Therefore, downregulation of integrin ␣ 6 may also be involved in the mechanisms accounting for the suppression of lung cancer cell invasion by PTEN. Because of its high association with deletion or mutation in many primary human cancers and several familial precancerous disorders, PTEN is thought to be a tumor suppressor gene (1-10). However, its exact cellular function remains unclear. PTEN encodes a 47-kD protein that contains the sequence motif highly conserved in the members with protein tyrosine phosphatase activity (8) . PTEN has been shown in vitro to possess phosphatase activity on phosphotyrosine and phosphoserine/threonine-containing synthetic substrate (24) . Cumulative evidence has shown that PTEN may play a critical role in regulating fundamental cellular function and tumor progression. PTEN can suppress cell growth and inhibit tumorigenesis (11, 12, 25) . The growth suppression of PTEN was mediated by its ability to block cell-cycle progression in the G1 phase. The cellcycle kinase inhibitor P27 K1P1 was significantly increased and protein kinase B/Akt was inhibited after expression of PTEN (19) . Loss of PTEN may result in decreased sensitivity of mutant cells to apoptotic stimuli and thereby allow them to survive and proliferate (18) . Recently, PTEN has been demonstrated in vitro to dephosphorylate phosphatidylinositol 3,4,5-triphosphate, a product of phosphatidylinositol 3 kinase (PI3 kinase) (15) . This is consistent with the notion that the phosphatase activity of PTEN is required for tumor suppressor activity. PTEN also has sequence similarity to tensin (1, 2) , which is a cytoskeletal protein that binds to actin filaments at focal adhesions and is tyrosinephosphorylated upon integrin-mediated cell adhesion (26) . Further, recent reports have indicated that PTEN not only Figure 8 . Representative PTEN-regulated genes were analyzed by Northern hybridization. To confirm the results of differentially expressed genes obtained by the cDNA microarray technique, each candidate cDNA clone was isolated and PCR-amplified, and its sequence confirmed. Northern hybridization was then performed using these representative cDNA clones as probes. A quantity of 1 g mRNA from each of the stable constitutive PTEN transfectants was electrophoresed and transferred to nylon membrane for hybridization. Clones 6 and 16 are PTEN-overexpressed clones, whereas clones 9 and 10 are mock transfectants. Suppression of EGF-like growth factor, Akt2, integrin ␣ 6 , and differentiationrelated gene 1 (Drg 1), and increased expression of ubiquitin protease (unph) and one EST clone were observed. The housekeeping gene GAPDH was used as an internal control in these experiments. Figure 9 . Flow cytometry analysis of integrin ␣ 6 expression by specific mAb in stable constitutive wild-type PTEN expression transfectants (clones 6 and 16) and mock transfectants (clones 9 and 10) revealed that ␣ 6 integrin expression was downregulated by PTEN (*P Ͻ 0.05 by Student's t test as compared with clone 9) (A). The flow cytometry analysis of integrin ␣ 6 expression in stable inducible PTEN expression transfectant pIND PTEN revealed that integrin ␣ 6 expression is suppressed after induction of PTEN overexpression by 1 M muristerone A (*P Ͻ 0.05 by Student's t test) (B). Each experiment was carried out in triplicate. The data are presented as means Ϯ SD.
can suppress growth of various cells and tumorigenicity, but also is capable of regulating cell biologic activities unrelated to growth. Tamura and colleagues demonstrated that overexpression of PTEN in NIH 3T3 fibroblasts can downmodulate integrin-mediated focal adhesion formation and organization of actin containing cytoskeleton through their intrinsic phosphatase activity (13) . They concluded that PTEN expression could suppress cell spreading and migration. Recently, Tamura and coworkers also demonstrated that PTEN could suppress cell invasion through dephosphorylation of focal adhesion kinase (27) . These data suggest that in addition to tumor suppressor activity, PTEN may also function in the regulation of dynamic cell-surface interactions that involve integrins, focal adhesion kinase, cell migration, and the cytoskeleton. Our results further confirm that PTEN may also play an important role in tumor progression by suppression of carcinoma invasion. The invasive ability of CL 1-5 cells was significantly reduced in both the PTEN-overexpressed stable constitutive and the inducible transfectants. The reduction of invasive abilities is associated with downregulation of integrin ␣ 6 expressions.
The exon 5 deletion is one of the hot spots for PTEN mutations. Furnari and associates previously reported two glioma cell lines with exon 5 deletion (11). The possible consequence of this deletion mutation may associate with inactivation of phosphatase activity and suppression of tumor growth (11) . However, there was no detailed information on the mutation site. In our cell line system, the cell growth was not significantly reduced in exon 5-deleted cells. We examined 15 lung cancer cell lines, two of which expressed exon 5 deletion at the same sites. Both of these two cell lines (PC14 and CL [1] [2] [3] [4] [5] ) showed higher invasive ability (data not shown). Because only limited cell lines were tested, further studies are necessary before we can draw any conclusions. Northern blot analysis showed that the CL 1-0 and CL 1-1 cells contain both wild-type and mutant PTEN. Possible explanations include the presence of splicing variants (11) or the presence of heterogeneous cell population due to genetic instability in cancer cells.
The results of cDNA microarray analysis in this study indicate that several migration-and invasion-related genes were modulated by PTEN overexpression. The expression of integrin ␣ 6 was reduced in PTEN-overexpressed clones both in mRNA and at the protein level. Other related genes, such as proto-oncogene protein kinase B/Akt, were downregulated by PTEN, whereas protein phosphatase 2A1B was upregulated by PTEN. These results are consistent with previous reports (19, 20) . The integrin ␣ 6 subunit, in combination with the ␤ 4 subunit, may form a heterodimer ␣ 6 ␤ 4 integrin. The integrin ␣ 6 ␤ 4 is a receptor for the laminins, and plays an important role in the biology of invasive carcinoma (28) . This integrin is essential for the organization and maintenance of epithelial structure (29) and may mediate the formation of stable adhesive structures, termed hemidesmosomes, that link the intermediate filament cytoskeleton with extracellular matrix (30) . Persistent expression of ␣ 6 ␤ 4 integrin is present in many tumor cells that do not form stable adhesive contacts but rather exhibit the motile phenotypic characteristic of invasive carcinoma (31) . A recent study indicates that ␣ 6 ␤ 4 integrin can promote carcinoma invasion through activation of PI3 kinase activity (19) . The integrin ␣ 6 ␤ 4 may regulate PI3 kinase activity and further activate a downstream small G protein Rac. Our data on integrin ␣ 6 is consistent with these previous reports (31) . PTEN may play a role in the suppression of carcinoma invasion through downregulation of integrin ␣ 6 subunit expression.
Phosphatidylinositol 3,4,5-triphosphate, a product of PI3 kinase, is a key molecule involved in the cell growth and signal transduction pathways. Recently, PTEN has been shown in vitro to dephosphorylate phosphatidylinositol 3,4,5-triphosphate (15) . This evidence suggests that PTEN may negatively regulate the intracellular level of phosphatidylinositol 3,4,5-triphosphate through direct dephosphorylation (15) . This process may also lead to decreased phosphorylation and activity of protein kinase B/ Akt (18) . Therefore, PTEN expression may inhibit Akt expression through the reduction of phosphatidylinositol 3,4,5-triphosphate level (18) . These results are consistent with the data obtained in this study by the cDNA microarray technique. Protein kinase B/Akt is a key signaling component lying downstream of PI3 kinase (20) . Akt-2 is a serine-threonine kinase that can phosphorylate several proteins which could mediate cell growth, apoptosis, and tumor progression (21, 22) . Both PI3 kinase and protein kinase B/Akt are involved in tumor progression and carcinoma invasion (18) (19) (20) (21) (22) . In a recent study of pancreatic ductal adenocarcinoma cell lines, transfection with antisense Akt2 constructs was able to inhibit tumorigenicity and invasiveness (23) . PI3 kinase activity is required for the formation of lamellae, dynamic sites of motility in carcinoma cells (19) . Protein phosphatase 2A is one of the enzymes involved in the maintenance of cytoskeletal polymerization and also influences tumor invasion and metastasis (32, 33) . Reduced phosphatase 2A enzyme activity has been demonstrated in metastatic cells as compared with nonmetastatic cells in Lewis lung carcinoma (34) . The nonmetastatic cells may acquire the invasive and cytoskeletal characteristics of metastatic cells upon inhibition of their serine/threonine protein phosphatase (35) . Our data show that protein phosphatase 2A1B is stimulated by PTENoverexpression, indicating that protein phosphatase 2A1B may also play a role in the suppression of invasive abilities in the PTEN-overexpressed CL 1-5 cells.
The cDNA microarray analysis also revealed a panel of proto-oncogene, kinase, and transcriptional factors which can be modulated by PTEN overexpression. Some of the functions of these genes have been previously reported and may possibly be related to tumor suppressor activity by PTEN. Some of these genes have never been reported before. Thus, the results of this study demonstrate the feasibility of the cDNA microarray technique in profiling thousands of downstream gene changes regulated by the tumor suppressor gene PTEN. Our cDNA microarray and color detection systems are highly accurate and easy to use. The quantitation accuracy is comparable with conventional Northern hybridization. The standard deviation of these systems is 7% (15) . We selected a cutoff value of a 2-fold difference for the differential expression of genes. Lowering the cutoff value would suggest that more genes had been modulated by PTEN. Therefore, due to the selection criteria for the cutoff valve, some of the genes affected by PTEN overexpression may not be included in Tables 1 and 2. In conclusion, PTEN overexpression may not only affect cell proliferation and tumorigenicity but also suppress migration and carcinoma invasion in our lung cancer cell line model. Using the high-density cDNA microarray technique, we were able to analyze the downstream gene changes modulated by PTEN. Our results show that downregulation of ␣ 6 and protein kinase B/Akt and upregulation of protein phosphatase 2A1B may also contribute to the suppression of invasive ability in PTEN-overexpressed cells. We also demonstrated the existence of a panel of genes that can be modulated by PTEN. Further studies are necessary to elucidate the exact function of these genes and their relationship to PTEN expression. The cDNA microarray technique may be useful in these investigations.
